𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis

✍ Scribed by Li Yuming; Zhang Zhongzhi; Deng Xiuling; Chen Lulu

Publisher
Springer-Verlag
Year
2005
Tongue
Chinese
Weight
296 KB
Volume
25
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Seven Years of Treatment with Risedronat
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
✍ D. D. MellstrΓΆm; O. H. SΓΆrensen; S. Goemaere; C. Roux; T. D. Johnson; A. A. Chin πŸ“‚ Article πŸ“… 2004 πŸ› Springer 🌐 English βš– 186 KB

The effects of 7 years of risedronate treatment were evaluated in a second 2-year extension of a 3-year vertebral fracture study in women with osteoporosis. For the first 5 years of the study, women received risedronate 5 mg/day or placebo according to the original randomization, with maintenance of